The company has steadily increased its investment in R&I, building expertise in areas such as gut health, sustainable ingredients and personalised nutrition. © DanoneFrom clinical nutrition to consumer brandsEsser explained that Danone’s medical nutrition arm is already applying microbiome research in hospitals. As microbiome science advances, she suggested the brand could incorporate additional strains to extend benefits into areas such as immunity. She added that many of Danone’s products are already built around biotics, meaning future scientific insights could be applied widely across the company’s portfolio. The Paris-Saclay inauguration builds on Danone’s broader R&I footprint, which includes its Singapore site dedicated to microbiology, immunology and data-driven health.